Pharmacy supporting Covid-19 public health trials in the community – PRINCIPLE Trial
The delivery of research studies in the pandemic has proven to be a significant challenge for many, including organisations such as the NIHR and those working in primary care. The PRINCIPLE study University of Oxford is the world’s largest clinical trial of its kind for the treatment of COVID-19 in the community and stands out as a flagship primary care COVID-19 study.
It is increasingly and often becoming an accepted norm by many, that recruitment into clinical trials of people living in socioeconomically deprived areas and those from ethnically diverse communities is generally poor compared to the larger population.
The PRINCIPLE trial is innovative in many ways, and in this instance incorporates a particular focus on how pharmacy and its wider network may be better utilised to help reach out to underserved communities and potentially enhance recruitment.
This is an opportunity for pharmacy to be recognised as a strength in supporting wider research within the community in developing the evidence base and ultimately improving health and health outcomes.